CME Group Inc.
CME
$267.85
$3.691.40%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.43B | 1.59B | 1.53B | 1.41B | 1.48B |
| Total Other Revenue | 104.00M | 102.60M | 107.60M | 108.80M | 106.60M |
| Total Revenue | 1.53B | 1.69B | 1.64B | 1.52B | 1.58B |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 1.53B | 1.69B | 1.64B | 1.52B | 1.58B |
| SG&A Expenses | 440.00M | 430.30M | 407.30M | 417.00M | 426.80M |
| Depreciation & Amortization | 82.60M | 83.40M | 82.50M | 83.40M | 83.90M |
| Other Operating Expenses | 39.20M | 45.70M | 41.60M | 70.00M | 47.00M |
| Total Operating Expenses | 561.80M | 559.40M | 531.40M | 570.40M | 557.70M |
| Operating Income | 972.60M | 1.13B | 1.11B | 952.30M | 1.02B |
| Income Before Tax | 1.18B | 1.33B | 1.24B | 1.10B | 1.18B |
| Income Tax Expenses | 269.00M | 305.20M | 288.60M | 222.00M | 264.10M |
| Earnings from Continuing Operations | 908.00M | 1.03B | 956.20M | 874.60M | 912.80M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 908.00M | 1.03B | 956.20M | 874.60M | 912.80M |
| EBIT | 972.60M | 1.13B | 1.11B | 952.30M | 1.02B |
| EBITDA | 1.06B | 1.21B | 1.19B | 1.04B | 1.11B |
| EPS Basic | 2.49 | 2.81 | 2.63 | 2.40 | 2.51 |
| Normalized Basic EPS | 2.05 | 2.31 | 2.16 | 1.89 | 2.05 |
| EPS Diluted | 2.49 | 2.81 | 2.62 | 2.40 | 2.50 |
| Normalized Diluted EPS | 2.04 | 2.31 | 2.16 | 1.89 | 2.04 |
| Average Basic Shares Outstanding | 359.69M | 359.66M | 359.61M | 359.57M | 359.40M |
| Average Diluted Shares Outstanding | 360.42M | 360.36M | 360.23M | 360.05M | 359.99M |
| Dividend Per Share | 1.25 | 1.25 | 1.25 | 1.15 | 1.15 |
| Payout Ratio | 50.14% | 44.42% | 268.50% | 47.88% | 45.85% |